Transitioning Patients From Second- to First-Line Prophylaxis in Hereditary Angioedema

Abstract

Modern targeted prophylaxis is recommended for patients with hereditary angioedema (HAE), but many remain on attenuated androgens. EMJ spoke to two HAE experts who explain how they help patients to make the switch.